W. Plochl et al., Support of mean arterial pressure during tepid cardiopulmonary bypass: Effects of phenylephrine and pump flow on systemic oxygen supply and demand, J CARDIOTHO, 13(4), 1999, pp. 441-445
Objective: To examine the effects of phenylephrine infusion and increases i
n pump flow on systemic oxygen supply and demand when they are used to supp
ort mean arterial pressure (MAP) during cardiopulmonary bypass (CPB).
Design: Prospective, unblinded study.
Setting: The animal cardiopulmonary laboratory at the Mayo Foundation (Roch
ester, MN).
Participants: Twelve pigs.
Interventions:Twelve pigs had systemic oxygen delivery ((D) over dot O-2) a
nd consumption ((V) over dot O-2) measured before CPB and then underwent CP
B at 35 degrees C. During CPB, measurements of (D) over dot O-2 and (V) ove
r dot O-2 were obtained at an MAP of approximately 50 mmHg and a pump flow
of 2.2 L/min/m(2). Thereafter, MAP was elevated to 70 mmHg either by increa
ses in pump flow or by a phenylephrine infusion, and the balance between sy
stemic oxygen supply and demand was reassessed.
Measurements and Main Results: Before CPB, (D) over dot O-2 was 375 +/- 83
mL/min/m(2) and decreased with the onset of CPB mainly because of the effec
ts of hemodilution. During CPB, with a pump flow of 2.2 L/min/m(2) and an M
AP of 53 mmHg, (D) over dot O-2 was 218 +/- 40 mL/min/m(2). Increasing perf
usion pressure to an MAP of 72 mmHg with phenylephrine and maintaining pump
flow constant (2.2 L/min/m(2)) did not change (D) over dot O-2 (222 +/- 37
mL/min/m(2)), and the oxygen extraction ratio (OER) was increased relative
to pre-CPB levels. In contrast, increasing MAP to 71 mmHg by increasing pu
mp flow to 3.2 L/min/m(2) resulted in a significantly greater (D) over dot
O-2 and the OER normalized to the pre-CPB value.
Conclusions: During CPB with conventional flow rates, (D) over dot O-2 is d
ecreased. supporting MAP with increases in pump flow better maintains (D) o
ver dot O-2 than the administration of an alpha-agonist. Copyright (C) 1999
by W.B. Saunders Company.